ArticleCell death & disease2024

Rupatadine-inhibited OTUD3 promotes DLBCL progression and immune evasion through deubiquitinating MYL12A and PD-L1.

Ying Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.